Eva Widing

507 total citations
10 papers, 293 citations indexed

About

Eva Widing is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Eva Widing has authored 10 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Eva Widing's work include Acute Lymphoblastic Leukemia research (3 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Cancer Mechanisms and Therapy (2 papers). Eva Widing is often cited by papers focused on Acute Lymphoblastic Leukemia research (3 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Cancer Mechanisms and Therapy (2 papers). Eva Widing collaborates with scholars based in Norway, Argentina and Switzerland. Eva Widing's co-authors include Rudolf Maibach, J. Plaschkes, Gordon A. MacKinlay, Bruce Morland, Giorgio Perilongo, Arthur Zimmermann, Derek Roebuck, Piotr Czauderna, Daniël C. Aronson and Laurence Brugières and has published in prestigious journals such as New England Journal of Medicine, Blood and Clinical & Experimental Immunology.

In The Last Decade

Eva Widing

9 papers receiving 288 citations

Peers

Eva Widing
R. Erttmann Germany
Pasquale Barbaro Australia
Diarmaid D. Houlihan Ireland
Lauren Weintraub United States
Jeannine Garnett United States
Fernanda Volt France
Robert Welschinger Australia
Toshihiro Onishi Japan
L Horwitz United States
Hilda Haynes United States
R. Erttmann Germany
Eva Widing
Citations per year, relative to Eva Widing Eva Widing (= 1×) peers R. Erttmann

Countries citing papers authored by Eva Widing

Since Specialization
Citations

This map shows the geographic impact of Eva Widing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Widing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Widing more than expected).

Fields of papers citing papers by Eva Widing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Widing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Widing. The network helps show where Eva Widing may publish in the future.

Co-authorship network of co-authors of Eva Widing

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Widing. A scholar is included among the top collaborators of Eva Widing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Widing. Eva Widing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Hasselblatt, Martin, Christian Thomas, Katharina Heß, et al.. (2016). AT-11CRIBRIFORM NEUROEPITHELIAL TUMOR (CRINET): MOLECULAR CHARACTERIZATION OF A SMARCB1-DEFICIENT NON-RHABDOID TUMOR WITH FAVORABLE LONG-TERM OUTCOME. Neuro-Oncology. 18(suppl 3). iii3.2–iii3.
2.
Ruud, Ellen, Adriani Kanellopoulos, Bernward Zeller, et al.. (2012). Senfølger etter akutt lymfatisk leukemi - hva vet pasientene?. Tidsskrift for Den norske legeforening. 132(18). 2052–2055. 20 indexed citations
3.
Brandal, Petter, Ludmila Gorunova, Eva Widing, et al.. (2011). Genomic aberrations in pediatric gliomas and embryonal tumors. Genes Chromosomes and Cancer. 50(10). 788–799. 6 indexed citations
4.
Perilongo, Giorgio, Rudolf Maibach, Laurence Brugières, et al.. (2009). Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma. New England Journal of Medicine. 361(17). 1662–1670. 205 indexed citations
5.
Widing, Eva, et al.. (2007). Bruk av naturpreparater og kosttilskudd hos kreftsyke barn i Norge. Tidsskrift for Den Norske Laegeforening. 1 indexed citations
6.
Widing, Eva, et al.. (2007). [Children with cancer and their use of natural products].. PubMed. 127(19). 2524–6. 5 indexed citations
7.
Stray‐Pedersen, Asbjørg, et al.. (2004). The impact of an early truncating founder ATM mutation on immunoglobulins, specific antibodies and lymphocyte populations in ataxia-telangiectasia patients and their parents. Clinical & Experimental Immunology. 137(1). 179–186. 30 indexed citations
8.
Abrahamsen, Tore G., Eva Widing, Anders Glomstein, & Peter Gaustad. (1992). Disseminated Fungal Disease Resistant to Fluconazole Treatment in a Child with Leukemia. Scandinavian Journal of Infectious Diseases. 24(3). 391–393. 13 indexed citations
9.
Alfsen, G. Cecilie, Klaus Beiske, Harald Holte, et al.. (1991). T-cell receptor tau delta +/CD3+4-8-T- cell acute lymphoblastic leukemias: a distinct subgroup of leukemias in children. A report of five cases. Blood. 77(9). 2023–2030. 12 indexed citations
10.
Alfsen, G. Cecilie, Klaus Beiske, Harald Holte, et al.. (1991). T-cell receptor tau delta +/CD3+4-8-T- cell acute lymphoblastic leukemias: a distinct subgroup of leukemias in children. A report of five cases. Blood. 77(9). 2023–2030. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Erttmann Breakdown of academic impact, for papers by Pasquale Barbaro Breakdown of academic impact, for papers by Diarmaid D. Houlihan Breakdown of academic impact, for papers by Lauren Weintraub Breakdown of academic impact, for papers by Jeannine Garnett Breakdown of academic impact, for papers by Fernanda Volt Breakdown of academic impact, for papers by Robert Welschinger Breakdown of academic impact, for papers by Toshihiro Onishi Breakdown of academic impact, for papers by L Horwitz Breakdown of academic impact, for papers by Hilda Haynes
Rankless by CCL
2026